Quiz
Key Barriers to Tardive Dyskinesia Diagnosis
Tardive dyskinesia (TD) is a hyperkinetic movement disorder that is often irreversible. It is typically caused by exposure to antipsychotic medications used to treat mental illnesses such as major depressive disorder, bipolar disorder, and schizophrenia. (source)
News
04/01/2026
Brionna Mendoza
A Phase 2b randomized clinical trial published in JAMA Psychiatry found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive...
A Phase 2b randomized clinical trial published in JAMA Psychiatry found nonsignificant differences in response rate between psilocybin 25 mg, psilocybin 5 mg, and placebo with supporting psychotherapy in treatment-resistant major depressive...
A Phase 2b randomized clinical...
04/01/2026
Psych Congress Network
Conference Insights
03/27/2026
Kristian Dambrino, DNP, APRN, MSN
Kristian Dambrino, DNP, PMHNP-BC, shares practical, patient-centered strategies for selecting antidepressants in major depressive disorder (MDD).
Kristian Dambrino, DNP, PMHNP-BC, shares practical, patient-centered strategies for selecting antidepressants in major depressive disorder (MDD).
Kristian Dambrino, DNP,...
03/27/2026
Psych Congress Network
News
03/24/2026
Brionna Mendoza
Research presented at NP Institute highlights α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulation as a promising therapeutic target.
Research presented at NP Institute highlights α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor modulation as a promising therapeutic target.
Research presented at NP...
03/24/2026
Psych Congress Network
News
03/24/2026
Brionna Mendoza
A research letter published in JAMA Psychiatry reports that reduced grip strength may represent a transdiagnostic marker across schizophrenia and depression, including remitted depression.
A research letter published in JAMA Psychiatry reports that reduced grip strength may represent a transdiagnostic marker across schizophrenia and depression, including remitted depression.
A research letter published in...
03/24/2026
Psych Congress Network
